West Coast Salmon, a Norwegian company with plans to build a massive land-based salmon operation in Nevada, filed for bankruptcy. The company reportedly lost close to NOK 100 million ($9.8 million) ...

Voters in the town of Jonesport, Maine, U.S.A. have approved an extension to the amount of time Kingfish Maine has to start its planned recirculating aquaculture system (RAS) facility. Kingfish filed ...

The RAS family commonly drives the growth and survival of human cancers. Mutations in KRAS, NRAS, and HRAS occur in approximately 20% of all human cancers, including solid tumors, such as pancreatic, ...

The Higher Education Commission (HEC), Pakistan, has announced exciting career opportunities for Pakistani nationals under its PSDP funded development project titled "Prime Minister's Scheme for ...

HEC Infra Projects Ltd has won a Rs 18.67 crore order from Engineering Projects (India) Limited for EPC work at Ukai TPS. The 10-month project involves HT/LT package services for a 500 MW unit's FGD ...

Your FREE registration gives you access to all our content: news and feature articles, regular and special guest columnists, Fish Farmer Magazine e-editions, yearbooks, archives, videos and more ...

The Public Works Authority (Ashghal) has announced the commencement of the Qatar Aeronautical Academy Development Project in Ras Bu Abboud as part of its ongoing efforts to develop advanced ...

HEC Infra Projects Ltd has closed its trading window from July 1, 2026, until 48 hours after the Q1FY27 results announcement, adhering to SEBI regulations. The board meeting date for the financial ...

Mumbai, June 16: HEC Infra Projects has received a work order worth ₹34.82 crore from M/s Stellar Manufacturers Private Limited for electrical package works at a food park project in Gujarat, ...

Get started with Microsoft Project in just 13 minutes! Follow this step-by-step beginner-friendly guide to plan, track, and manage your projects with ease. #MicrosoftProject #ProjectManagement ...

This year’s meeting of the American Society of Clinical Oncology is abuzz with talk of RAS inhibitors, largely driven by Revolution Medicines’ barnburner pancreatic cancer data drop earlier this year.